Leukotriene B4 plays a pivotal role in CD40-dependent activation of chronic B lymphocytic leukemia cells

Blood

Volumn 105, Issue 3, 2005, Pages 1274-1279

  Runarsson, Gudmundur ^b   Liu, Anquan ^b   Mahshid, Yilmaz ^b   Feltenmark, Stina ^b   Pettersson, Annika ^b   Klein, Eva ^b   Björkholm, Magnus ^b   Claesson, Hans Erik ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; CD150 ANTIGEN; CD23 ANTIGEN; CD40 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR ANTAGONIST; LIPOXYGENASE INHIBITOR; CELL ADHESION MOLECULE; ICAM3 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; BIOSYNTHESIS; BONE MARROW CELL; CELL ACTIVATION; CELL ISOLATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; DRUG INHIBITION; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; RECEPTOR AFFINITY; AGED; CELL CULTURE; PATHOLOGY; PHYSIOLOGY;

AGED; ANTIGENS, CD; CELL ADHESION MOLECULES; FEMALE; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LEUKOTRIENE B4; LIPOXYGENASE INHIBITORS; MALE; TUMOR CELLS, CULTURED;

EID: 12844258796     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-07-2546     Document Type: Article

References (47)

1. Claesson H-E, Dahlen S-E. Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs. J Intern Med. 1999;245:205-227.
2. 4. Biochem Biophys Res Commun. 1991;178:302-308.
3. Jakobsson PJ, Steinhilber D, Odlander B, Radmark O, Claesson H-E, Samuelsson B. On the expression and regulation of 5-lipoxygenase in human lymphocytes. Proc Natl Acad Sci U S A. 1992;89:3521-3525.
4. Jakobsson PJ, Shaskin P, Larsson P, et al. Studies on the regulation and localization of 5-lipoxygenase in human B-lymphocytes. Eur J Biochem. 1995;232:37-46.
5. Werz O, Steinhilber D. Selenium-dependent peroxidases suppress 5-lipoxygenase activity in B-lymphocytes and immature myeloid cells: the presence of peroxidase-insensitive 5-lipoxygenase activity in differentiated myeloid cells. Eur J Biochem. 1996;242:90-97.
6. 3. Adv Exp Med Biol. 1997;433:383-386.
7. Werz O, Klemm J, Radmark O, Samuelsson B. p38 MAP kinase mediates stress-induced leukotriene synthesis in a human B-lymphocyte cell line. J Leukoc Biol. 2001;70:830-838.
8. Owman C, Nilsson C, Lolait SJ. Cloning of cDNA encoding a putative chemoattractant receptor. Genomics. 1996;37:187-194.
9. 4 is the functional ligand binding to and activating the cloned chemoattractant receptor, CMKRL1. Biochem Biophys Res Commun. 1997;240:162-166.
10. 4 that mediates chemotaxis. Nature. 1997;387:620-624.
11. 4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat Immunol. 2003;4:965-973.
12. 4. Nat Immunol. 2003;4:974-981.
13. 4 receptor BLT1 mediates early effector T cell recruitment. Nat Immunol. 2003;4:982-990.
14. 4 receptor, BLT1, in human bone marrow and peripheral blood using specific monoclonal antibodies. Int Immunopharmacol. 2003;3:1467-1475.
15. 4 receptor. Biochem Biophys Res Commun. 2000;274:377-382.
16. 4 receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med. 2000;192:421-432.
17. 4 in the immune system. Int J Immunopharmacol. 1992;14:441-449.
18. 4 potentiates the expression and release of Fc epsilon RII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL-4. J Immunol. 1990;145:3406-3411.
19. 4 enhances activation, proliferation, and differentiation of human B lymphocytes. J Immunol. 1989;143:1996-2000.
20. 4 enhances IL-4-induced IgE production from normal human lymphocytes. Cell Immunol. 1994;156:124-134.
21. 4 induces human suppressor lymphocytes. Biochem Biophys Res Commun. 1982;108:1531-1537.
22. + lymphocyte phenotype and immunoregulatory functions. J Immunol. 1985;135:1357-1360.
23. Björck P, Paulie S. CD40 antibodies defining distinct epitopes display qualitative differences in their induction of B cell differentiation. Immunology. 1996;87:291-295.
24. Kindler V, Zubler RH. Memory, but not naive, peripheral blood B lymphocytes differentiate into Ig-secreting cells after CD40 ligation and co-stimulation with IL-4 and the differentiation factors IL-2, IL-13 and IL-3. J Immunol. 1997;159:2085-2090.
25. Sakata N, Hamelmann E, Siadak AW, et al. Differential regulation of CD40-mediated human B cell responses by antibodies directed against different CD40 epitopes. Cell Immunol. 2000;201:109-123.
26. Takeuchi H, Kayano H, Hirose T. Differences in IgE isotype switching induced by a CD40 monoclonal antibody and cytokines among subtypes of chronic B lymphoid leukemias. Exp Hematol. 2000;28:543-550.
27. Domingo A, Gonzalez-Barca E, Castellsague X, et al. Expression of adhesion molecules in 113 patients with B-cell chronic lymphocytic leukemia: relationship with clinico-prognostic features. Leuk Res. 1997;21:67-73.
28. Lucio PJ, Faria MT, Pinto AM, et al. Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders. Haematologica. 1998;83:104-111.
29. Punnonen J, Cocks BG, Carballido JM, et al. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J Exp Med. 1997;185:993-1004.
30. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503-511.
31. Kuppers R, Klein U, Schwering I, et al. Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest. 2003;111:529-537.
32. Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194:1639-1647.
33. Stratowa C, Loffler G, Lichter P, et al. cDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking. Int J Cancer. 2001;91:474-480.
34. Garrone P, Neidhardt EM, Garcia E, Galibert L, van Kooten C, Banchereau J. Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med. 1995;182:1265-1273.
35. 4 receptor-1. Biochem Biophys Res Commun. 2000;279:520-525.
36. Gillard J, Ford-Hutchinson AW, Chan C, et al. L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2, 2-dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor. Can J Physiol Pharmacol. 1989;67:456-464.
37. Bhattacherjee P, Boughton-Smith NK, Follenfant RL, et al. The effects of a novel series of selective inhibitors of arachidonate 5-lipoxygenase on anaphylactic and inflammatory responses. Ann N Y Acad Sci. 1988;524:307-320.
38. 2, 5-lipoxygenase and prostaglandin H synthase 2 in acute pre B-lymphocytic leukemia. Br J Haematol. 1995;90:585-594.
39. 4. Biochem Biophys Res Commun. 1985;131:579-585.
40. 4: interactions with granulocyte-macrophage colony-stimulating factor. Blood. 1993;81:352-356.
41. Dittmann KH, Mayer C, Rodemann HP, Petrides PE, Denzlinger C. MK-886, a leukotriene biosynthesis inhibitor, induces antiproliferative effects and apoptosis in HL-60 cells. Leuk Res. 1998;22:49-53.
42. Khan MA, Hoffbrand AV, Mehta A, Wright F, Tahami F, Wickremasinghe RG. MK 886, an antagonist of leukotriene generation, inhibits DNA synthesis in a subset of acute myeloid leukaemia cells. Leuk Res. 1993;17:759-762.
43. Christiansen I, Gidlof C, Wallgren AC, Simonsson B, Totterman TH. Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers. Blood. 1994;84:3010-3016.
44. Fournier S, Yang LP, Delespesse G, Rubio M, Biron G, Sarfati M. The two CD23 isoforms display differential regulation in chronic lymphocytic leukaemia. Br J Haematol. 1995;89:373-379.
45. Sarfati M, Chevret S, Chastang C, et al. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood. 1996;88:4259-4264.
46. Schwarzmeier JD, Shehata M, Hilgarth M, et al. The role of soluble CD23 in distinguishing stable and progressive forms of B-chronic lymphocytic leukemia. Leuk Lymphoma. 2002;43:549-554.
47. 4-induced hyperadhesiveness of endothelial cells for neutrophils: relation to CD54. Clin Exp Immunol. 1992;90:300-304.